Education
About Us
Working with TipRanks
Follow Us
Epigral Ltd (IN:EPIGRAL)
:EPIGRAL
EPIGRAL Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹1,506.60 - ₹2,408.35
Previous CloseN/A
Volume42.70K
Average Volume (3M)6.84K
Market Cap
₹79.20B
Enterprise Value₹86.84B
Total Cash (Recent Filing)₹987.90M
Total Debt (Recent Filing)₹5.93B
Price to Earnings (P/E)18.1
Beta1.46
Next Earnings
Nov 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 20, 2025Dividend Yield0.32%
Share Statistics
EPS (TTM)16.10
Shares Outstanding43,141,340
10 Day Avg. Volume14,247
30 Day Avg. Volume6,841
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)4.21
Price to Sales (P/S)3.14
P/FCF Ratio32.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Epigral Ltd News
EPIGRAL FAQ
What was Epigral Ltd’s price range in the past 12 months?
Epigral Ltd lowest stock price was ₹1506.60 and its highest was ₹2408.35 in the past 12 months.
What is Epigral Ltd’s market cap?
Epigral Ltd’s market cap is ₹79.20B.
When is Epigral Ltd’s upcoming earnings report date?
Epigral Ltd’s upcoming earnings report date is Nov 06, 2025 which is in 88 days.
How were Epigral Ltd’s earnings last quarter?
Epigral Ltd released its earnings results on Aug 02, 2025. The company reported ₹16.1 earnings per share for the quarter, missing the consensus estimate of ₹17.45 by -₹1.35.
Is Epigral Ltd overvalued?
According to Wall Street analysts Epigral Ltd’s price is currently Overvalued.
Does Epigral Ltd pay dividends?
Epigral Ltd pays a Semiannually dividend of ₹3.5 which represents an annual dividend yield of 0.32%. See more information on Epigral Ltd dividends here
What is Epigral Ltd’s EPS estimate?
Epigral Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epigral Ltd have?
Epigral Ltd has 43,141,340 shares outstanding.
What happened to Epigral Ltd’s price movement after its last earnings report?
Epigral Ltd reported an EPS of ₹16.1 in its last earnings report, missing expectations of ₹17.45. Following the earnings report the stock price went up 0.788%.
Which hedge fund is a major shareholder of Epigral Ltd?
Currently, no hedge funds are holding shares in IN:EPIGRAL
Company Description
Epigral Ltd
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products. The company serves various sectors, including CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.
Technical Analysis
Gufic Biosciences Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Supriya Lifescience Limited
―